Asthma Clinical Pathway – Inpatient
Asthma Clinical Pathway – Inpatient
Asthma Control Assessment
| < 5 yrs Is this the second asthma exacerbation requiring systemic steroids in 6 mos? |
|
|---|---|
| ≥ 5 yrs Is this the second exacerbation requiring systemic steroids in 12 mos? |
Stepwise Recommended Medication Escalation Treatment for Managing Asthma Long Term
Adapted from 2020 Focused Updates to the Asthma Management Guidelines: Clinician's Guide
| Step 1 | Step 2 | Step 3 | Step 4 | Step 5 | Step 6 | |
|---|---|---|---|---|---|---|
| Symptoms | Intermittent | Mild Persistent | Moderate Persistent | Severe Persistent | ||
| 0–4 yrs* Preferred |
|
|
Medium-dose: ICS and PRN SABA |
Daily medium-dose: ICS-LABA and PRN SABA |
Daily high-dose: ICS-LABA and PRN SABA |
Daily high-dose: ICS-LABA + OCS and PRN SABA |
| 5–11 yrs Preferred | SABA as needed for symptoms | Daily low-dose: ICS and PRN SABA |
Daily and PRN combination low-dose: ICS-formoterol |
Daily and PRN medium-dose: ICS-formoterol |
Daily high-dose: ICS-LABA and PRN SABA |
Daily high-dose: ICS-LABA + OCS and PRN SABA |
| ≥ 12 yrs Preferred | SABA as needed for symptoms | Daily low-dose: ICS and PRN SABA or PRN concomitant ICS and SABA |
Daily and PRN combination low-dose: ICS-formoterol |
Daily and PRN combination medium-dose: ICS-formoterol |
Daily medium- or high-dose: ICS-LABA + LAMA and PRN SABA |
Daily high-dose: ICS-LABA + OCS + PRNs SABA |
| Quick Relief |
|
|||||
| *Adapted from 2020 NHLBI Asthma Focused Updates Highlighted table cells are consistent with SMART | ||||||
API, Preschool Age
Early frequent wheezer (≥ 3x) and 1 major or 2 minor.
| Major Criteria |
|
|---|---|
| Minor Criteria |
|